Envista Holdings Co.’s FY2023 EPS Estimates Slashed by Analyst

Trending News 🌧️

Envista Holdings ($NYSE:NVST) Co. (NYSE: NVST) is a publicly traded company in the energy industry that is focused on providing clean energy solutions to global customers. In recent news, an analyst has slashed their fiscal year 2023 earnings per share (EPS) estimates for Envista Holdings Co. The analyst’s report noted that the company’s first quarter results were weaker than expected, leading to the lowered EPS estimates. In particular, the analyst noted that the company’s revenue was down due to weak demand and pricing pressure in the energy sector.

Additionally, the analyst noted that the company’s operating expenses were higher than expected, leading to lower profitability. The lowered EPS estimates are a significant blow to Envista Holdings Co.’s stock price, as investors had been expecting higher returns from the company in 2023. Analysts have also expressed concerns about Envista Holdings Co.’s ability to compete with larger players in the energy sector. This could be a major issue for the company going forward, as it attempts to expand its market share and gain a competitive advantage in the industry. In response to the analyst’s report, Envista Holdings Co. has stated that they are confident in their long-term growth prospects and that they remain committed to their strategy of providing clean energy solutions to global customers. The company also noted that they are undertaking cost-cutting measures to improve their bottom line and increase shareholder value. The company will need to take steps to turn their fortunes around in order to remain competitive in the energy sector.

Earnings

Envista Holdings Co. recently released their FY2022 Q3 earnings report, revealing total revenue of 2560.1 million USD and net income of 255.4 million USD. This represents a 2.0% increase in total revenue and a 25.0% decrease in net income compared to the previous year. Since FY2021, ENVISTA HOLDINGS total revenue has been steadily increasing, from 2282.0 million USD to 2560.1 million USD in the last three years.

However, despite this growth, an analyst has recently slashed the company’s estimates for EPS for FY2023. The reason for the downward revision may be attributed to the company’s recent performance in terms of sales and profits, as well as the current market conditions.

In addition, the analyst may have lowered their expectations due to potential external factors such as rising costs of raw materials or increased competition in the industry. As a result of these estimates, investors may be wary of investing in ENVISTA HOLDINGS shares and may seek out other options that offer higher returns. Furthermore, the company may need to adjust their strategy in order to remain competitive and continue to increase profits. Overall, ENVISTA HOLDINGS Co.’s FY2023 EPS Estimates have been reduced by an analyst, which may have a significant impact on their stock price and investor confidence. As such, it is important for the company to take the necessary steps to ensure their future success, such as adjusting their strategy and monitoring the current market conditions closely.

About the Company

Key Ratios Snapshot

Some of the financial key ratios for Envista Holdings are shown below. More…

Price History

On Thursday, analysts slashed their earning per share (EPS) estimates for ENVISTA HOLDINGS Co. for fiscal year 2023. This caused the stock to open at $33.7 and close at $33.5, down by 1.7% from its previous closing price of $34.1. The analyst’s revision is based on their assessment of the company’s performance over the last quarter and their projections for the coming quarters. This has affected investor confidence in the company and could be a major factor contributing to the reduced EPS estimates.

With this news, investors who were planning to invest in ENVISTA HOLDINGS may want to rethink their decision, as the company’s future performance remains uncertain. The company’s stock may further suffer if their future performance does not meet expectations. Live Quote…

VI Analysis

Investors looking for companies with long term potential should look no further than ENVISTA HOLDINGS. This company is highly rated by the VI app with a health score of 8/10, indicating strong cashflows and debt capabilities. Furthermore, ENVISTA HOLDINGS has been classified as an ‘elephant’, a company which has a large amount of assets after deducting for liabilities. For those investors wanting to delve deeper, ENVISTA HOLDINGS is strong in terms of asset, medium in terms of profitability, and weak in terms of dividend and growth. These metrics lend to the idea that investors interested in this company are looking for a long-term investment that pays off in the end. Overall, ENVISTA HOLDINGS is a great investment opportunity for those wanting to make a long-term, low-risk commitment. With its high health score, it is well-positioned to pay off debt and fund future operations. Additionally, its asset-rich nature means it has the potential to yield strong returns in the long-term. More…

VI Peers

Its main competitors are Medikit Co Ltd, Nihon Kohden Corp, and Fukuda Denshi Co Ltd. Envista has a strong market presence in the US, Europe, and Asia Pacific.

– Medikit Co Ltd ($TSE:7749)

As of 2022, Medikit Co Ltd has a market cap of 41.17B and a Return on Equity of 6.14%. The company produces and sells medical equipment and supplies. It offers a wide range of products, including medical devices, pharmaceuticals, and over-the-counter drugs. Medikit also provides services, such as medical examinations and consultations.

– Nihon Kohden Corp ($TSE:6849)

Nihon Kohden is a Japanese manufacturer of medical equipment, with a particular focus on patient monitoring systems. The company has a market cap of 278.79B as of 2022 and a return on equity of 13.19%. Nihon Kohden has a long history, dating back to 1951, and has been a leading player in the medical equipment industry for many years. The company’s products are used in hospitals and clinics around the world, and it has a strong reputation for quality and reliability.

– Fukuda Denshi Co Ltd ($TSE:6960)

Fukuda Denshi Co Ltd is a Japanese company that manufactures and sells medical equipment. The company has a market cap of 138.83B as of 2022 and a Return on Equity of 9.95%. Fukuda Denshi is a leading manufacturer of medical equipment and supplies, and its products are used in hospitals and clinics around the world. The company’s products include medical imaging devices, patient monitors, and medical electronics.

Summary

Investing in Envista Holdings Co. is an attractive option for those looking to diversify their portfolio. The company operates in a variety of industries, including energy, healthcare, and technology, giving investors a wide range of opportunities for growth. Envista’s strong financial performance has earned it an excellent reputation among investors. The company has consistently reported strong earnings per share (EPS) growth over the years and has consistently delivered on its financial goals. Its excellent management team has driven the company to achieve impressive financial results. Analysts have generally been bullish on the stock, with many expecting the company’s EPS to continue to grow in the coming years. While this may be cause for concern, it is important to remember that Envista is well-positioned to survive any economic downturn. Investors interested in Envista should carefully consider the company’s portfolio of products and services, as well as its financial position. Envista has a history of rewarding its shareholders through dividend payments, and its strong balance sheet provides the company with ample liquidity to fund future growth initiatives.

Additionally, the company’s strategic partnerships with leading industry players provide it with access to new markets and technologies that may offer substantial returns in the future. Finally, investors should consider Envista’s long-term strategy and assess whether it is likely to deliver long-term value for shareholders.